Header Logo

Connection

THOMAS KOSTEN to Drug Resistance, Neoplasm

Back to Details
This is a "connection" page, showing publications THOMAS KOSTEN has written about Drug Resistance, Neoplasm.
THOMAS KOSTEN
Connection Strength
0.184
Drug Resistance, Neoplasm
  1. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694.
    View in: PubMed
    Score: 0.184
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.